RxDoctor Payments Data

Emamuzo Otobo

Internal Medicine · Bronx, NYNPI 1932601580

Payments from drug & device makers

$4,516in general payments, 2019–2025

Across 88 payments — averaging $51.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$1K
  • Boston Scientific$775
  • Novartis$375
  • Abiomed$212
  • Astellas Pharma US Inc$199
  • Artivion, Inc.$191
  • plus $1K from 17 others

What the payments were for

  • Food & beverage$3,83085%
  • Education$68615%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,516 in reported general payments places this provider in the 85th percentile of 9,771 internal medicine providers in New York.

See all internal medicine providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban28$37,086
JardianceEmpagliflozin25$24,099
EntrestoSacubitril/Valsartan17$19,773
XareltoRivaroxaban22$16,126
Atorvastatin Calcium194$2,731
Nifedipine ErNifedipine60$1,940
Losartan Potassium66$673
Ezetimibe25$517
Carvedilol75$502
Amlodipine Besylate81$461
Lisinopril77$384
Hydralazine Hcl25$379
Chlorthalidone17$363
Metoprolol Succinate47$350
Rosuvastatin Calcium22$316

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$20$37,08628 claims
NovartisEntresto$375$19,77317 claims
Johnson & JohnsonXarelto$184$16,12622 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 9,771 internal medicine providers in New York.

Other internal medicine in Bronx

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →